Delivery Order SPE2DR25D2014-SPE2DR26FA0D7
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,442.67 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen (0.5ml), a diabetes medication. This is a firm fixed price delivery order with an ultimate completion date of October 30, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,113.37 for Mounjaro 2.5 mg/0.5 mL pen injectables, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,088.36 for Mounjaro 15 mg/0.5 mL pen injections on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at approximately $1...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.08 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical products to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $15,070.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 10, 2025, with an ultimate completion date of July 11, 2025. This delivery order is a non-set-aside competitive award fulfilled through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,446.90 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $4,214.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections. The contract, which represents a non-set-aside competitive award, is scheduled for completion by November 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0D7Delivery Order
The Defense Logistics Agency awarded a $13,898.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pen injectable medication, with an ultimate completion date of December 19, 2025. This non-set-aside competitive award leverages AmerisourceBergen's position as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is executed under a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical SPE2DX contract valued at $999,999,999.00 through December 2026—which provides comprehensive pharmaceutical support for military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major for-profit pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company maintains an extensive portfolio of federal medical procurement contracts covering specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Mounjaro, a diabetes medication, exemplifies AmerisourceBergen's ongoing role in supplying medications essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 12/17/25 |